For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted ...

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

Teva Pharmaceutical Industries Ltd. ADR 26.47% $18.82B ...

肖比·拉玛克里希南早期职业生涯的大部分时间都在硅谷度过。作为葛兰素史克（GSK）的首席数字与技术官（CDTO），拉玛克里希南在苹果（Apple）和赛富时（Salesforce）等科技巨头工作了多年，后来转向日益技术化的制药行业。

GSK has revealed the data it hopes will ... which avoid the lengthy and cumbersome manufacturing and treatment process needed for CAR-Ts. These are also currently FDA-approved for later-line ...

"We respect the agency's approach to the accelerated approval regulations and associated process," commented GSK's chief medical officer Sabine Luik. "Multiple myeloma is a challenging disease ...

They have two manufacturing units in India, located at Nashik and Thane. Also, they have a clinical development centre in Bangalore. GlaxoSmithKline Pharma Limited was incorporated in November 13 ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Depemokimab (GSK-3511294) is under development for the ...